American Society for Microbiology, Clinical and Vaccine Immunology, 5(20), p. 761-764, 2013
DOI: 10.1128/cvi.00081-13
Full text: Download
Anti-tumor necrosis factor alpha (anti-TNF-α) is used in the treatment of rheumatic diseases not responsive to first-line regimens. Data on the safety of anti-TNF-α in HIV-infected patients are scarce and conflicting. We describe a case of septic shock and multiorgan failure that occurred after etanercept initiation and influenza vaccination in an HIV-infected woman with rheumatoid arthritis. Copyright © 2013, American Society for Microbiology. All Rights Reserved.